FACTORS DETERMINING THE RESPONSE FOR TREATMENT WITH MONOCLONAL ANTIBODIES TO RANKL (DENOSUMAB) IN WOMEN WITH RHEUMATOID ARTHRITIS AND OSTEOPOROSIS

P. S. Kovalenko; I. S. Dydykina; A. V. Smirnov; E. L. Nasonov

doi:10.14341/osteo12814-9920

For citations:

Kovalenko P.S., Dydykina I.S., Smirnov A.V., Nasonov E.L. FACTORS DETERMINING THE RESPONSE FOR TREATMENT WITH MONOCLONAL ANTIBODIES TO RANKL (DENOSUMAB) IN WOMEN WITH RHEUMATOID ARTHRITIS AND OSTEOPOROSIS. Osteoporosis and Bone Diseases. 2020;23(2):73. (In Russ.)

Views PDF (Rus): 87

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).

ISSN 2072-2680 (Print)
ISSN 2311-0716 (Online)

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

Osteoporosis and Bone Diseases

For citations:

Cookies policy